Home Cascadian Therapeutics

Cascadian Therapeutics

acquired
IPO Delisting
Developer of Synthetic Vaccines and Targeted Small Molecule Drugs
Basic
Enterprise Profile

Basic Information

Cascadian Therapeutics is a clinical-stage biopharmaceutical company primarily focused on the development of therapeutic products for the treatment of cancer. The company aims to develop and commercialize novel synthetic vaccines and targeted small molecules to enhance the treatment potential and quality of life for cancer patients.
Cascadian Therapeutics, Inc.
Seattle,Washington,United States of America
51~100 people
January 01, 1985
--
bd@oncothyreon.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Vaccine Formulation Production
Technology
Targeted Technology
Concept
Disease Treatment Tumor
Application Scenarios
Chemical Drug Innovative Drugs Traditional Vaccines (Biological Products for Prevention)